Impact of Breathing Pattern and Nebulization on Expelled Viral Content During Mechanical Ventilation Using an Ex Vivo Porcine Lung System

REFERENCES

1. 1.↵
   1. Hauswirth DW,
   2. Sundy JS

   . Bioaerosols and innate immune responses in airway diseases. Curr Opin Allergy Clin Immunol 2004;4(5):361-366.

   OpenUrlPubMed
2. 2.↵
   1. Soma M,
   2. Jacobson I,
   3. Brewer J,
   4. Blondin A,
   5. Davidson G,
   6. Singham S

   . Operative team checklist for aerosol generating procedures to minimize exposure of health care workers to SARS-CoV-2. Int J Pediatr Otorhinolaryngol 2020;134:110075.

   OpenUrl
3. 3.↵
   1. Blachere FM,
   2. Lindsley WG,
   3. Pearce TA,
   4. Anderson SE,
   5. Fisher M,
   6. Khakoo R,
   7. et al

   . Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 2009;48(4):438-440.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Benge CD,
   2. Barwise JA

   . Aerosolization of COVID-19 and contamination risks during respiratory treatments. Fed Pract 2020;37(4):160-163.

   OpenUrl
5. 5.↵
   Global Initiative for Asthma (GINA). COVID-19: GINA answers to frequently asked questions on asthma management. Available at: https://ginasthma.org/covid-19-gina-answers-to-frequently-asked-questions-on-asthma-management.
6. 6.↵
   World Health Organization. Coronavirus disease (COVID-19) technical guidance: patient management, 2020.
7. 7.↵
   1. Chu DK,
   2. Akl EA,
   3. Duda S,
   4. Solo K,
   5. Yaacoub S,
   6. Schünemann HJ

   ; COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020;395(10242):1973-1987.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Bourouiba L,
   2. Dehandschoewercker E,
   3. Bush JW

   . Violent expiratory events: on coughing and sneezing. J Fluid Mech 2014;745:537-563.

   OpenUrl
9. 9.↵
   1. Lloyd-Smith JO,
   2. Schreiber SJ,
   3. Kopp PE,
   4. Getz WM

   . Super-spreading and the effect of individual variation on disease emergence. Nature 2005;438(7066):355-359.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Manunta MDI,
    2. McAnulty RJ,
    3. McDowell A,
    4. Jin J,
    5. Ridout D,
    6. Fleming J,
    7. et al

    . Airway deposition of nebulized gene delivery nanocomplexes monitored by radio-imaging agents. Am J Respir Cell Mol Biol 2013;49(3):471-480.

    OpenUrl
11. 11.↵
    1. Judge EP,
    2. Hughes JML,
    3. Egan JJ,
    4. Maguire M,
    5. Molloy EL,
    6. O'Dea S

    . Anatomy and bronchoscopy of the porcine lung. A model for translational respiratory medicine. Am J Respir Cell Mol Biol 2014;51(3):334-343.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Klassen C,
    2. Eckert CE,
    3. Wong J,
    4. Guyette JP,
    5. Harris JL,
    6. Thompson S,
    7. et al

    . Ex vivo modeling of perioperative air leaks in porcine lungs. IEEE Trans Biomed Eng 2018;65(12):2827-2836.

    OpenUrlCrossRef
13. 13.
    1. Perinel S,
    2. Pourchez J,
    3. Leclerc L,
    4. Avet J,
    5. Durand M,
    6. Prévôt N,
    7. et al

    . Development of an ex vivo human-porcine respiratory model for preclinical studies. Sci Rep 2017;7:43121.

    OpenUrl
14. 14.↵
    1. Dutta R,
    2. Xing T,
    3. Murdoch GK

    . Comparison of pressure, volume, and gas wash-out characteristics between PCV and HFPV in healthy and formalin-fixed ex vivo porcine lungs. Physiol Meas 2018;39(9):095003.

    OpenUrl
15. 15.↵
    1. Mehaffey JH,
    2. Charles EJ,
    3. Sharma AK,
    4. Money DT,
    5. Zhao Y,
    6. Stoler MH,
    7. et al

    . Airway pressure release ventilation during ex vivo lung perfusion attenuates injury. J Thorac Cardiovasc Surg 2017;153(1):197-204.

    OpenUrl
16. 16.↵
    1. Turgeon N,
    2. Toulouse M-J,
    3. Martel B,
    4. Moineau S,
    5. Duchaine C

    . Comparison of five bacteriophages as models for viral aerosol studies. Appl Environ Microbiol 2014;80(14):4242-4250.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Eninger RM,
    2. Honda T,
    3. Adhikari A,
    4. Heinonen-Tanski H,
    5. Reponen T,
    6. Grinshpun SA

    . Filter performance of n99 and n95 face-piece respirators against viruses and ultrafine particles. Ann Occup Hyg 2008;52(5):385-396.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Gendron L,
    2. Verreault D,
    3. Veillette M,
    4. Moineau S,
    5. Duchaine C

    . Evaluation of filters for the sampling and quantification of RNA phage aerosols. Aerosol Sci Technol 2010;44(10):893-901.

    OpenUrlCrossRef
19. 19.↵
    1. Ross BB,
    2. Gramiak R,
    3. Rahn H

    . Physical dynamics of the cough mechanism. J Appl Physiol 1955;8(3):264-268.

    OpenUrlPubMedWeb of Science
20. 20.↵
    1. Bem RA,
    2. van Mourik N,
    3. Klein-Blommert R,
    4. Spijkerman IJ,
    5. Kooij S,
    6. Bonn D,
    7. Vlaar AP

    . Risk of aerosol formation during high-flow nasal cannula treatment in critically ill subjects. Respir Care 2021;66(6):891-896.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Avari H,
    2. Hiebert RJ,
    3. Ryzynski AA,
    4. Levy A,
    5. Nardi J,
    6. Kanji-Jaffer H,
    7. et al

    . Quantitative assessment of viral dispersion associated with respiratory support devices in a simulated critical-care environment. Am J Respir Crit Care Med 2021;203(9):1112-1118.

    OpenUrl
22. 22.↵
    1. Blau H,
    2. Mussaffi H,
    3. Mei Zahav M,
    4. Prais D,
    5. Livne M,
    6. Czitron BM,
    7. et al

    . Microbial contamination of nebulizers in the home treatment of cystic fibrosis. Child Care Health Dev 2007;33(4):491-495.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Van Doremalen N,
    2. Bushmaker T,
    3. Morris DH,
    4. Holbrook MG,
    5. Gamble A,
    6. Williamson BN,
    7. et al

    . Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382(16):1564-1567.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Tran K,
    2. Cimon K,
    3. Severn M,
    4. Pessoa-Silva CL,
    5. Conly J

    . Aerosol-generating procedures and risk of transmission of acute respiratory infections to health care workers: a systematic review. PloS One 2012;7(4):e35797.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Reychler G,
    2. Vecellio L,
    3. Dubus JC

    ; ‘group Aerosoltherapy GAT’ of the French Language Respiratory Society-Société de Pneumologie de Langue Française SPLF. Nebulization: a potential source of SARS-CoV-2 transmission. Respir Med Res 2020;78:100778.

    OpenUrlCrossRef
26. 26.↵
    1. Amirav I,
    2. Newhouse MT

    . Transmission of coronavirus by nebulizer: a serious, underappreciated risk. CMAJ 2020;192(13):E346.

    OpenUrlFREE Full Text
27. 27.↵
    1. Mei-Zahav M,
    2. Amirav I

    . Aerosol treatments for childhood asthma in the era of COVID-19. Pediatr Pulmonol 2020;55(8):1871-1872.

    OpenUrl
28. 28.↵
    1. Dhand R,
    2. Li J

    . Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med 2020;202(5):651-659.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Wiggs BR,
    2. Bosken C,
    3. Paré PD,
    4. James A,
    5. Hogg JC

    . A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145(6):1251-1258.

    OpenUrlCrossRefPubMedWeb of Science